ASX:DUR
ASX:DURConstruction

ASX Stocks Estimated To Be Trading Below Fair Value In September 2025

As the Australian market navigates through the typical September sell-off season, investors are closely watching sectors like energy and healthcare for signs of resilience amid fluctuating gold prices and anticipation of a US Federal Reserve decision. In this environment, identifying stocks trading below their fair value can be a strategic move, as these opportunities may offer potential for growth once market conditions stabilize.
ASX:MMA
ASX:MMAMetals and Mining

ASX Penny Stocks To Consider In September 2025

As the Australian market experiences its typical September sell-off, investors are closely watching sectors like energy and healthcare for signs of stability amidst fluctuating gold prices and anticipation of a US Federal Reserve decision. In such volatile times, identifying stocks with strong financials becomes crucial, especially when considering smaller or newer companies that might offer both affordability and growth potential. While the term "penny stocks" may seem outdated, these...
TSX:TSL
TSX:TSLMetals and Mining

TSX Penny Stocks To Watch In September 2025

As markets anticipate potential rate cuts from the Bank of Canada and the Fed, investors are keeping a close eye on economic indicators that could influence future monetary policy decisions. Amidst this backdrop, penny stocks—often representing smaller or newer companies—remain an intriguing area for those seeking growth opportunities at lower price points. While the term might seem outdated, these stocks can offer significant potential when backed by strong financials and solid fundamentals.
NYSE:CWAN
NYSE:CWANSoftware

Clearwater Analytics Holdings (CWAN) Powers Agile Investment Management With Unified Platform

Clearwater Analytics Holdings (CWAN) experienced a 1% price move over the last month. This period saw the company make significant strides, including its partnership with Agile Investment Management to provide integrated risk and performance analytics solutions, showcasing its advanced technological capabilities. Additionally, the announcement of a $100 million share buyback program reflected management's confidence in the company's value. While these initiatives may have supported the...
NYSE:VRT
NYSE:VRTElectrical

Vertiv Holdings Co (VRT) Reports Doubling Net Income In Strong Q2 Earnings

Vertiv Holdings Co (VRT) recently declared a quarterly cash dividend of $0.04 per share, which may have boosted shareholder confidence. Over the last quarter, the company's stock price increased by 16%, a performance influenced by several key developments. In July, the company reported strong Q2 earnings, with revenue rising to $2,638 million and net income nearly doubling year-over-year. This robust performance aligns with broader market trends as major stock indices reached record highs,...
ASX:REG
ASX:REGHealthcare

Regis Healthcare (ASX:REG) Announces Revenue Surge to A$1,292 Million

Regis Healthcare (ASX:REG) recently reported a strong financial rebound with a significant increase in revenue to AUD 1,292 million and a net income of AUD 49 million, contrasting its previous year's loss. Additionally, the announcement of higher dividends reflects the company's commitment to shareholder returns. These developments likely supported a 13% rise in its share price over the last quarter. During this time, global stock markets, including major indices like the Nasdaq and S&P 500,...
NYSE:CRC
NYSE:CRCOil and Gas

California Resources (CRC) Engages In M&A Discussions With Berry Corporation

California Resources (CRC) recently held discussions regarding potential mergers and acquisitions with Berry Corporation, hinting at potential growth in the energy sector. This development, along with a robust earnings report showing significant revenue and net income growth, likely supported CRC's solid 13% stock price increase over the last quarter. Coupled with a substantial stock buyback, which could enhance shareholder value, these factors added positive weight to CRC's performance. Amid...
NasdaqGS:SYRE
NasdaqGS:SYREBiotechs

Spyre Therapeutics (SYRE) Doses First Patient In Promising SPY072 Phase 2 Trial

Spyre Therapeutics (SYRE) recently dosed the first patient in its Phase 2 SKYWAY basket trial, a key development this past quarter. The company's share price rose 3% in the last quarter, aligning closely with broader market trends, as the Nasdaq Composite and S&P 500 saw record highs. While Spyre's advancement in clinical trials for SPY072 could strengthen investor confidence, market expectations of Federal Reserve interest rate cuts and overall bullish sentiment in tech stocks might have...
TSX:CHP.UN
TSX:CHP.UNRetail REITs

Choice Properties Real Estate Investment Trust (TSX:CHP.UN) Declares C$0.064 Cash Distribution for September

Choice Properties Real Estate Investment Trust (TSX:CHP.UN) announced the affirmation of its September dividend, with a cash distribution of $0.064 per trust unit, which could have supported its stock's 6% rise over the past month. This aligns with the broader market positivity, as the Nasdaq and S&P 500 reached record highs amid anticipations of Federal Reserve interest rate decisions. The announcement of a steady dividend provides a degree of stability and potential income, which may have...
NasdaqGS:REAL
NasdaqGS:REALSpecialty Retail

RealReal (REAL) Shows Earnings Improvement in Q2 2025

The RealReal (REAL) recently announced its Q2 2025 earnings on August 7, showcasing a significant improvement in financials, including a marked reduction in net loss and an increase in revenue compared to the previous year. The company's share price experienced a notable move of 83% over the last quarter, potentially influenced by its robust earnings performance, alongside the broader market's bullish trend as the Nasdaq and S&P 500 reached record highs. The appointment of Mark McCaffrey to...
SEHK:1858
SEHK:1858Medical Equipment

Beijing Chunlizhengda Medical Instruments (SEHK:1858) Sees 31% Stock Rise Over Last Quarter

Beijing Chunlizhengda Medical Instruments (SEHK:1858) achieved robust financial growth, posting a 30% net income increase for the first half of 2025 and earnings per share growth from CNY 0.21 to CNY 0.30. While the company's stock rose 31% over the last quarter, broader market trends also showed an upward trajectory, with major indices like the Nasdaq and S&P 500 hitting record highs. This rise was supported by investor optimism surrounding potential interest rate cuts by the Federal...
NYSE:PEB
NYSE:PEBHotel and Resort REITs

Pebblebrook Hotel Trust (PEB) Declares Regular Q3 Dividends on Preferred and Common Shares

Pebblebrook Hotel Trust (PEB) recently declared cash dividends for both common and preferred shares, reflecting its commitment to shareholder returns. Over the last quarter, the company saw a 23% increase in share price. This positive performance coincided with announcements of steady dividends and revised full-year earnings guidance, reducing expected net losses. Despite a decline in net income for the second quarter, PEB's overall financial stability and consistent dividend payouts might...
NasdaqGS:NVCR
NasdaqGS:NVCRMedical Equipment

NovoCure (NVCR) Gains Japan Approval For Optune Lua® In NSCLC Treatment Combo

NovoCure (NVCR) recently secured approval for its Optune Lua® device in Japan, a milestone for the company’s TTFields therapy that targets non-small cell lung cancer. This development aligns with the company’s strategic efforts to broaden its therapy applications. Over the past month, NovoCure's stock rose 3.58%. This movement was largely in line with market trends, as broader stock indexes experienced gains ahead of anticipated interest rate cuts by the Federal Reserve. The approval of...
OB:BAKKA
OB:BAKKAFood

P/F Bakkafrost (OB:BAKKA) Adjusts Production Guidance for 2026 to 104,000 Tonnes

P/F Bakkafrost (OB:BAKKA) recently adjusted its production guidance for 2026, increasing to 104,000 tonnes due to strong regional performance, despite posting a net loss in its Q2 2025 financial results. Over the past month, the company's share price moved up by 12%, aligning with general market trends that saw significant gains due to broader economic optimism, including anticipated rate cuts by the Federal Reserve. This positive production outlook combined with a complex mix of market and...
SEHK:1347
SEHK:1347Semiconductor

Hua Hong Semiconductor (SEHK:1347) Reports Increased Sales And Net Income In Q2 2025 Earnings

Hua Hong Semiconductor (SEHK:1347) reported a price increase of 68%, aligning with the tech sector's rallies echoed in Nasdaq reaching new highs. The August announcement of Q2 2025 earnings showed increased sales and net income, supporting the positive market sentiment. With upcoming board meetings considering interim results and potential dividends, along with maintained projections for Q3 revenue growth, investor confidence is likely bolstered. Meanwhile, broader market conditions such as...